In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events: Release of stock exchange notification. Press release, quarterly ...

The goal of conducting a fast-tracked nuclear test can only be political, not scientific. The United States has much to lose ...

The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.